title: Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.
authors.affiliation: University of Toronto Lupus Clinic Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital Toronto, Ontario, Canada Department of Medicine University of Toronto and Department of Medicine Women's College Hospital Toronto, Ontario, Canada Mecklinger Family and Posluns Family Cardiac Catheterization Research Laboratory Department of Medicine Division of Cardiology Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada Fred A. Litwin Family Centre in Genetic Medicine Department of Medicine Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada University Health Network Pathology Department Toronto General Research Institute Toronto, Ontario, Canada University of Toronto Lupus Clinic Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital Toronto, Ontario, Canada m.urowitz@utoronto.ca.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tselios
authors.forename: Dafna D
authors.initials: DD
authors.lastname: Gladman
authors.forename: Paula
authors.initials: P
authors.lastname: Harvey
authors.forename: Susanna
authors.initials: S
authors.lastname: Mak
authors.forename: Morel
authors.initials: M
authors.lastname: Chantal
authors.forename: Jagdish
authors.initials: J
authors.lastname: Butany
authors.forename: Murray B
authors.initials: MB
authors.lastname: Urowitz
mesh_terms: D000368:Aged; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects; D009202:Cardiomyopathies / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D018450:Disease Progression; D004452:Echocardiography / Q000379:methods; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods; D012720:Severity of Illness Index; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D000962:Antimalarials; D006886:Hydroxychloroquine